A Study To Investigate How The Body Handles Multiple Doses Of PF-0243873 And To Investigate The Effect Of PF-02413873 On Sex Hormone Levels In Healthy Young Women

Completed · Phase 1 · Has a placebo group

Conditions studied: Endometriosis

In brief

The study will investigate how well multiple doses of PF-02413873 are tolerated by healthy young women, how the body handles multiple doses of PF-02413873 and which effect PF-02413873 has on sex hormones in healthy young women

Key facts

Study ID

NCT00800618

Run by

Pfizer

People needed

42

Starts

2008-11-01

Expected to finish

2009-06-01

Last updated by the study team

2010-02-10

Who can join

Age: 18 and older, up to 35. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Healthy women of childbearing potential with a regular menstrual cycle

You may not qualify if…

• Evidence or history of any major disease
• Pregnant or nursing women
• Requirement for chronic medication

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States
• Pfizer Investigational Site — Overland Park, Kansas, United States
• Pfizer Investigational Site — Overland Park, Kansas, United States
• Pfizer Investigational Site — Brussels, Belgium

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.